M Wullt

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi request reprint Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial
    Marlene Wullt
    Department of Infectious Diseases, University Hospital Malmo, Malmo, Sweden
    Scand J Infect Dis 35:365-7. 2003
  2. ncbi request reprint Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile
    M Wullt
    Department of Infectious Diseases, University Hospital Malmo, SE 205 02 Malmo, Sweden
    J Hosp Infect 55:124-30. 2003
  3. ncbi request reprint A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea
    Marlene Wullt
    Department of Infectious Diseases, University Hospital, Malmo, Sweden
    J Antimicrob Chemother 54:211-6. 2004
  4. pmc Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid
    T Noren
    Department of Infectious Diseases, Orebro University Hospital, S 701 85 Orebro, Sweden
    Antimicrob Agents Chemother 50:3028-32. 2006
  5. pmc Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile
    T Noren
    Department of Infectious Diseases, Orebro University Hospital, SE 701 85 Orebro, Sweden
    Antimicrob Agents Chemother 51:1840-3. 2007
  6. pmc IgG antibody response to toxins A and B in patients with Clostridium difficile infection
    M Wullt
    Infectious Diseases Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Clin Vaccine Immunol 19:1552-4. 2012
  7. doi request reprint Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics
    B Klarin
    Department of Anaesthesiology and Intensive Care, University Hospital, Lund, Sweden
    Acta Anaesthesiol Scand 52:1096-102. 2008
  8. doi request reprint A head-to-head comparison of hydrogen peroxide vapor and aerosol room decontamination systems
    T Holmdahl
    Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Infect Control Hosp Epidemiol 32:831-6. 2011
  9. ncbi request reprint Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
    Inga Odenholt
    Infectious Diseases Research Unit, Department of Clinical Sciences, Malmo, Sweden
    Chemotherapy 53:267-74. 2007
  10. pmc Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1
    Thomas Akerlund
    Swedish Institute for Infectious Disease Control, Department of Bacteriology, SE 171 82, Solna, Sweden
    J Clin Microbiol 46:1530-3. 2008

Detail Information

Publications12

  1. ncbi request reprint Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial
    Marlene Wullt
    Department of Infectious Diseases, University Hospital Malmo, Malmo, Sweden
    Scand J Infect Dis 35:365-7. 2003
    ..plantarum in patients with RCDAD, these results may contribute to the ongoing discussion about the benefits of probiotics in patients with RCDAD and encourage the performance of larger multicentre studies...
  2. ncbi request reprint Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile
    M Wullt
    Department of Infectious Diseases, University Hospital Malmo, SE 205 02 Malmo, Sweden
    J Hosp Infect 55:124-30. 2003
    ..We conclude, that of these two PCR-based options for typing of C. difficile PCR ribotyping offers a superior experimental robustness compared with AP-PCR typing...
  3. ncbi request reprint A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea
    Marlene Wullt
    Department of Infectious Diseases, University Hospital, Malmo, Sweden
    J Antimicrob Chemother 54:211-6. 2004
    ..Few treatment options are currently available to treat patients suffering from an initial episode of Clostridium difficile-associated diarrhoea (CDAD)...
  4. pmc Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid
    T Noren
    Department of Infectious Diseases, Orebro University Hospital, S 701 85 Orebro, Sweden
    Antimicrob Agents Chemother 50:3028-32. 2006
    ..Development of resistance in C. difficile was frequent in patients given fusidic acid, but it was without apparent negative impact on therapeutic efficacy in the actual CDAD episode...
  5. pmc Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile
    T Noren
    Department of Infectious Diseases, Orebro University Hospital, SE 701 85 Orebro, Sweden
    Antimicrob Agents Chemother 51:1840-3. 2007
    ..Five of these mutations have previously been described in fusA of fusidic acid-resistant Staphylococcus aureus, but seven were novel fusA mutations. Fusidic acid monotherapy for CDAD seemed to rapidly select conserved resistant mutants...
  6. pmc IgG antibody response to toxins A and B in patients with Clostridium difficile infection
    M Wullt
    Infectious Diseases Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Clin Vaccine Immunol 19:1552-4. 2012
    ..The results imply that the general serum reactivity against toxins A and B in the population reduces the risk of CDI, which suggests implications for vaccine strategies...
  7. doi request reprint Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics
    B Klarin
    Department of Anaesthesiology and Intensive Care, University Hospital, Lund, Sweden
    Acta Anaesthesiol Scand 52:1096-102. 2008
    ..We investigated intensive care unit (ICU) patients with respect to the impact of Lp299v on C. difficile colonisation and on gut permeability and parameters of inflammation and infection in that context...
  8. doi request reprint A head-to-head comparison of hydrogen peroxide vapor and aerosol room decontamination systems
    T Holmdahl
    Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Infect Control Hosp Epidemiol 32:831-6. 2011
    ..There are several hydrogen peroxide-based area decontamination technologies on the market, but no head-to-head studies have been performed...
  9. ncbi request reprint Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
    Inga Odenholt
    Infectious Diseases Research Unit, Department of Clinical Sciences, Malmo, Sweden
    Chemotherapy 53:267-74. 2007
    ..Pharmacodynamic studies of antibiotics have attracted great interest in recent years. However, studies on the pharmacodynamics of different antibiotics against Clostridium difficile are scarce...
  10. pmc Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1
    Thomas Akerlund
    Swedish Institute for Infectious Disease Control, Department of Bacteriology, SE 171 82, Solna, Sweden
    J Clin Microbiol 46:1530-3. 2008
    ..Type 027 produced 3- to 13-fold more toxin than did major Swedish types. One epidemic strain (027/NAP1a) sporulated more than did other type 027 isolates, a feature that should contribute to its survival and spread...
  11. ncbi request reprint Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea
    Marlene Wullt
    Infectious Diseases Research Unit, Department of Clinical Sciences, Lund University, 20502 Malmo, Sweden
    Dig Dis Sci 52:2082-6. 2007
    ..The intake of this probiotic strain may thereby provide an additional benefit for patients with recurrent Clostridium difficile-associated diarrhea...
  12. ncbi request reprint Activity of three disinfectants and acidified nitrite against Clostridium difficile spores
    Marlene Wullt
    Department of Infectious Diseases, Lund University, Malmo University Hospital, Malmo, Sweden
    Infect Control Hosp Epidemiol 24:765-8. 2003
    ..To identify environmentally safe, rapidly acting agents for killing spores of Clostridium difficile in the hospital environment...